Ohio State University spinout Entrada Therapeutics has pocketed $116m in a series B round.

MD Anderson Cancer Center spinout OncoResponse has added $40.6m to its coffers thanks to series C investors including Arch Venture Partners.

The Seek Group, Laureate Education and BCC-backed online learning platform developer priced its shares at the top of their range.

Susquehanna Growth Equity has returned to back the Citi and PNG-backed accounting software provider’s latest round, which was raised at a $3.1bn valuation.

The Coinbase, Samsung, Animoca Brands, Alphabet, Endeavor and Axiomatic-backed virtual trading card manager is reportedly now valued at $2.6bn.

SoftBank’s SB Management subsidiary, Illumina and Novartis are backing a $375m PIPE supporting the deal, which values the proteomics technology provider at $1.23bn.

Ingka Group-backed vertical farm operator Aerofarms is joining forces with a special purpose acquisition company at a $1.2bn post-transaction valuation.

Blockchain-focused venture firm Dragonfly Capital Partners’ second vehicle has partnerships with Bitmain, Bybit, Huobi and OKEx.

Cash Capital has returned for OnQuality Pharmaceuticals’s latest round, having already participated in a $15m series A in 2019.

Existing backers Lilly Asia Ventures and Osage University Partners helped the UCSF cancer therapy spinout close its series A round.